help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weirich, G.
Right arrow Articles by Brauch, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weirich, G.
Right arrow Articles by Brauch, H.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 11 5241-5246
Copyright © 2002 by The Endocrine Society


Original Article

VHL2C Phenotype in a German von Hippel-Lindau Family with Concurrent VHL Germline Mutations P81S and L188V

Gregor Weirich, Bettina Klein, Thorsten Wöhl, Dieter Engelhardt and Hiltrud Brauch

Institute of Pathology (G.W.), Technische Universität München, D-81675 Munich; Wilex Biotechnology GmbH (T.W.), D-81675 Munich; Medical Department II (D.E.), Klinikum Grosshadern, University of Munich, D-81366 Munich; and Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (B.K., H.B.), D-70376 Stuttgart, Germany

Address all correspondence and requests for reprints to: Dr. Hiltrud Brauch, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Auerbachstrasse 112, D-70376 Stuttgart, Germany. E-mail: hiltrud.brauch{at}ikp-stuttgart.de.

Abstract

Von Hippel-Lindau disease (VHL) is a multitumor syndrome that develops on the basis of germline mutations in the VHL tumor suppressor gene. Genotype-phenotype correlations have helped to stratify the disease into VHL type 1 (without pheochromocytoma) and VHL type 2A, 2B, and 2C (with pheochromocytoma). VHL2C is characterized by a pheochromocytoma-only phenotype. We report on the P81S germline mutation in a German VHL2C family with the previously identified L188V mutation. The concurrent P81S mutation was identified by novel screening approaches including denaturing HPLC and sequencing. We show the co-segregation of these two mutations with the disease and discuss their possible impact on pVHL function and phenotype.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
F. J. Hes, J. W. M. Hoppener, and C. J. M. Lips
Pheochromocytoma in Von Hippel-Lindau Disease
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 969 - 974.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society